Skip Navigation LinksHead-Neck

​​​​Head and Neck Trials


Cancer Control/Prevention 


EA3132: Phase II Randomized Trial of Adjuvant Radiotherapy with or Without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)​


​A091404: A Phase II Study of Enzalutamide (NSC#766085) for Patients with Androgen Receptor Positive Salivary Cancers​


A091​305:  A Phase 2 Study of Efatutazone, an Oral PPAR Agonist, In Combination with Paclitaxel in Patients with Advanced Anaplastic Thyroid Cancer